Jethro Hu

1.3k total citations
34 papers, 471 citations indexed

About

Jethro Hu is a scholar working on Genetics, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jethro Hu has authored 34 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 11 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jethro Hu's work include Glioma Diagnosis and Treatment (20 papers), Cancer, Hypoxia, and Metabolism (8 papers) and Brain Metastases and Treatment (7 papers). Jethro Hu is often cited by papers focused on Glioma Diagnosis and Treatment (20 papers), Cancer, Hypoxia, and Metabolism (8 papers) and Brain Metastases and Treatment (7 papers). Jethro Hu collaborates with scholars based in United States, Switzerland and France. Jethro Hu's co-authors include Keith L. Black, John S. Yu, Chirag G. Patil, Miriam Nuño, Santosh Kesari, Jeremy Rudnick, Serguei Bannykh, Debraj Mukherjee, Dwain K. Irvin and Anthony Yi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Jethro Hu

32 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jethro Hu United States 13 295 139 112 93 85 34 471
Jonathan Weller Germany 11 261 0.9× 152 1.1× 116 1.0× 44 0.5× 127 1.5× 31 504
Marta Padovan Italy 13 282 1.0× 91 0.7× 76 0.7× 90 1.0× 79 0.9× 47 435
Christine Lu‐Emerson United States 8 234 0.8× 169 1.2× 119 1.1× 126 1.4× 99 1.2× 19 551
Ardi Pambuku Italy 11 451 1.5× 174 1.3× 190 1.7× 130 1.4× 167 2.0× 27 648
Sigmund Hsu United States 9 318 1.1× 160 1.2× 88 0.8× 116 1.2× 160 1.9× 26 498
Giulia Cerretti Italy 10 281 1.0× 107 0.8× 77 0.7× 66 0.7× 78 0.9× 30 402
Henning Leske Switzerland 10 160 0.5× 125 0.9× 79 0.7× 85 0.9× 67 0.8× 25 396
Luisa Bellu Italy 13 465 1.6× 162 1.2× 158 1.4× 128 1.4× 218 2.6× 43 690
E. Cohen-Jonathan Moyal France 7 239 0.8× 102 0.7× 81 0.7× 98 1.1× 108 1.3× 25 355
Yoshie Umemura United States 10 209 0.7× 108 0.8× 83 0.7× 66 0.7× 80 0.9× 43 387

Countries citing papers authored by Jethro Hu

Since Specialization
Citations

This map shows the geographic impact of Jethro Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jethro Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jethro Hu more than expected).

Fields of papers citing papers by Jethro Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jethro Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jethro Hu. The network helps show where Jethro Hu may publish in the future.

Co-authorship network of co-authors of Jethro Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Jethro Hu. A scholar is included among the top collaborators of Jethro Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jethro Hu. Jethro Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bannykh, Serguei, et al.. (2023). Very long-term survival of an older glioblastoma patient after treatment with cilengitide: a case report. CNS Oncology. 12(2). CNS96–CNS96. 1 indexed citations
3.
Gresham, Gillian, Sungjin Kim, Mourad Tighiouart, et al.. (2023). The ketogenic diet plus standard of care for adults with recently diagnosed glioblastoma: Results from a phase 1 trial.. Journal of Clinical Oncology. 41(16_suppl). 2076–2076. 2 indexed citations
4.
Gresham, Gillian, et al.. (2020). Exploring the Feasibility and Effects of a Ketogenic Diet in Patients With CNS Malignancies: A Retrospective Case Series. Frontiers in Neuroscience. 14. 390–390. 26 indexed citations
5.
Rudnick, Jeremy, J. Manuel Sarmiento, Benjamin R. Uy, et al.. (2020). A phase I trial of surgical resection with Gliadel Wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant glioma. Journal of Clinical Neuroscience. 74. 187–193. 37 indexed citations
6.
7.
Green, Stacey, Albert Lai, Richard Green, et al.. (2017). Report of safety of pulse dosing of lapatinib with temozolomide and radiation therapy for newly-diagnosed glioblastoma in a pilot phase II study. Journal of Neuro-Oncology. 134(2). 357–362. 23 indexed citations
8.
Hu, Jethro, et al.. (2016). Brainstem Glioma in Adults. Frontiers in Oncology. 6. 180–180. 35 indexed citations
9.
Sarmiento, J. Manuel, Debraj Mukherjee, Keith L. Black, et al.. (2016). Do Long-Term Survivor Primary Glioblastoma Patients Harbor IDH1 Mutations?. Journal of Neurological Surgery Part A Central European Neurosurgery. 77(3). 195–200. 9 indexed citations
10.
Connelly, Jennifer, et al.. (2016). Planning TTFields treatment using the NovoTAL system-clinical case series beyond the use of MRI contrast enhancement. BMC Cancer. 16(1). 842–842. 14 indexed citations
11.
Phuphanich, Surasak, Christopher J. Wheeler, Jeremy Rudnick, et al.. (2016). ATIM-25. TEN-YEAR FOLLOW UP WITH LONG TERM REMISSION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) TREATED WITH ICT-107 VACCINE (PHASE I). Neuro-Oncology. 18(suppl_6). vi23–vi23. 3 indexed citations
12.
Phuphanich, Surasak, Christopher J. Wheeler, Jeremy Rudnick, et al.. (2016). OS2.5 Long term remission/survival over 8 years in patients with newly diagnosed glioblastoma (GBM) treated with ICT-107 dendritic cell-based immunotherapy (phase I). Neuro-Oncology. 18(suppl_4). iv5–iv5. 1 indexed citations
13.
14.
Hu, Jethro & Santosh Kesari. (2012). The Molecular Basis for Novel Therapies. The Cancer Journal. 18(1). 32–39. 3 indexed citations
15.
Hu, Jethro, Patrick Y. Wen, Lauren E. Abrey, et al.. (2012). A phase II trial of oral gimatecan for recurrent glioblastoma. Journal of Neuro-Oncology. 111(3). 347–353. 20 indexed citations
16.
Carico, Christine, Miriam Nuño, Debraj Mukherjee, et al.. (2012). Loss of PTEN Is Not Associated with Poor Survival in Newly Diagnosed Glioblastoma Patients of the Temozolomide Era. PLoS ONE. 7(3). e33684–e33684. 55 indexed citations
17.
Patil, Chirag G., Paula Eboli, & Jethro Hu. (2012). Management of Multifocal and Multicentric Gliomas. Neurosurgery Clinics of North America. 23(2). 343–350. 16 indexed citations
18.
Hu, Jethro & Santosh Kesari. (2012). Strategies for overcoming the blood–brain barrier for the treatment of brain metastases. CNS Oncology. 2(1). 87–98. 2 indexed citations
19.
Patil, Chirag G., Miriam Nuño, Debraj Mukherjee, et al.. (2012). High levels of phosphorylated MAP kinase are associated with poor survival among patients with glioblastoma during the temozolomide era. Neuro-Oncology. 15(1). 104–111. 19 indexed citations
20.
Ozawa, Tomoko, Jethro Hu, Lily Hu, et al.. (2005). Functionality of hypoxia-induced BAX expression in a human glioblastoma xenograft model. Cancer Gene Therapy. 12(5). 449–455. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan Weller Breakdown of academic impact, for papers by Marta Padovan Breakdown of academic impact, for papers by Christine Lu‐Emerson Breakdown of academic impact, for papers by Ardi Pambuku Breakdown of academic impact, for papers by Sigmund Hsu Breakdown of academic impact, for papers by Giulia Cerretti Breakdown of academic impact, for papers by Henning Leske Breakdown of academic impact, for papers by Luisa Bellu Breakdown of academic impact, for papers by E. Cohen-Jonathan Moyal Breakdown of academic impact, for papers by Yoshie Umemura
Rankless by CCL
2026